BONH
VRTX icon

Bank of New Hampshire’s Vertex Pharmaceuticals VRTX Stock Holding History

Bank of New Hampshire’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-7
Closed -$3.12K – 470
2025
Q2 		$3.12K Hold
7
– – ﹤0.01% 442
2025
Q1 		$3.39K Hold
7
– – ﹤0.01% 431
2024
Q4 		$2.82K Hold
7
– – ﹤0.01% 434
2024
Q3 		$3.26K Hold
7
– – ﹤0.01% 432
2024
Q2 		$3.28K Hold
7
– – ﹤0.01% 453
2024
Q1 		$2.93K Hold
7
– – ﹤0.01% 454
2023
Q4 		$2.85K Hold
7
– – ﹤0.01% 449
2023
Q3 		$2.43K Hold
7
– – ﹤0.01% 456
2023
Q2 		$2.46K Buy
+7
New +$2.36K ﹤0.01% 470

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Bank of New Hampshire's VRTX Position: Q3 2025 in Review

Bank of New Hampshire sold out of Vertex Pharmaceuticals (VRTX) in Q3 2025, closing a stake of 7 shares — an estimated $3.12K sold.

Bank of New Hampshire first reported a position in VRTX in Q2 2023 and held it in 9 quarters. The position peaked at $3.39K in Q1 2025. 1,520 funds tracked by Wall St. Rank hold VRTX as of Q3 2025.

  • Bank of New Hampshire reported no remaining Vertex Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Bank of New Hampshire sold 7 Vertex Pharmaceuticals shares in Q3 2025, an estimated $3.12K.
  • Bank of New Hampshire first reported a position in Vertex Pharmaceuticals in Q2 2023 and held it in 9 quarters.
  • Bank of New Hampshire's Vertex Pharmaceuticals position peaked at $3.39K in Q1 2025.
  • 1,520 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2025.

Based on Bank of New Hampshire's 13F filing for Q3 2025, filed 2 Oct 2025.